Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 854912 | ISIN: US0091581068 | Ticker-Symbol: AP3
Tradegate
23.01.25
21:46 Uhr
311,00 Euro
+6,60
+2,17 %
Branche
Chemie
Aktienmarkt
S&P 500
1-Jahres-Chart
AIR PRODUCTS & CHEMICALS INC Chart 1 Jahr
5-Tage-Chart
AIR PRODUCTS & CHEMICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
310,20311,2022:03
310,00311,5022:00
PR Newswire
130 Leser
Artikel bewerten:
(0)

Air Products Reports Preliminary Voting Results from 2025 Annual Meeting of Shareholders

Finanznachrichten News

Welcomes Andrew Evans, Paul Hilal, Bob Patel, Dennis Reilley and Alfred Stern

LEHIGH VALLEY, Pa., Jan. 23, 2025 /PRNewswire/ -- Air Products (NYSE: APD) today reported preliminary voting results from its 2025 Annual Meeting of Shareholders ("Annual Meeting") held on January 23, 2025.

Based on preliminary results, Air Products shareholders have chosen to elect the following nominees to serve on the Company's Board of Directors:

  • Tonit M. Calaway
  • Lisa A. Davis
  • Andrew Evans
  • Jessica Trocchi Graziano
  • Paul Hilal
  • Bhavesh V. ("Bob") Patel
  • Dennis Reilley
  • Wayne T. Smith
  • Alfred Stern

The Company issued the following statement:

"We welcome all our new directors and look forward to working together in the advancement of our Company. We thank our outgoing directors, Casey Cogut, Seifi Ghasemi, David Ho, Ed Monser, and Matthew Paull, for their dedication and years of service to Air Products. We appreciate the engagement and dialogue we have had with all our shareholders throughout this process and reiterate our commitment to delivering meaningful, long-term value."

The final voting results, as tabulated by an independent inspector of elections, will be reported on a Form 8-K that will be filed with the Securities and Exchange Commission (SEC) in the coming days and will be available on the SEC's website at www.sec.gov and on the Company's Investor Relations website. The Board intends to meet promptly to address various matters, including reconstitution of committees, appointment of a Chair, and CEO succession planning. In the interim, Mr. Ghasemi will continue as the CEO of the Company.

About Air Products

Air Products (NYSE:APD) is a world-leading industrial gases company in operation for over 80 years focused on serving energy, environmental, and emerging markets and generating a cleaner future. The Company supplies essential industrial gases, related equipment and applications expertise to customers in dozens of industries, including refining, chemicals, metals, electronics, manufacturing, medical and food. As the leading global supplier of hydrogen, Air Products also develops, engineers, builds, owns and operates some of the world's largest clean hydrogen projects, supporting the transition to low- and zero-carbon energy in the industrial and heavy-duty transportation sectors. Through its sale of equipment businesses, the Company also provides turbomachinery, membrane systems and cryogenic containers globally.

Air Products had fiscal 2024 sales of $12.1 billion from operations in approximately 50 countries and has a current market capitalization of over $65 billion. Approximately 23,000 passionate, talented and committed employees from diverse backgrounds are driven by Air Products' higher purpose to create innovative solutions that benefit the environment, enhance sustainability and reimagine what's possible to address the challenges facing customers, communities, and the world. For more information, visit www.airproducts.com or follow us on LinkedIn, X, Facebook or Instagram.

This release contains "forward-looking statements" within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's expectations and assumptions as of the date of this release and are not guarantees of future performance. While forward-looking statements are made in good faith and based on assumptions, expectations and projections that management believes are reasonable based on currently available information, actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024 and other factors disclosed in our filings with the Securities and Exchange Commission. Except as required by law, we disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect any change in the assumptions, beliefs or expectations or any change in events, conditions or circumstances upon which any such forward-looking statements are based.

SOURCE Air Products

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.